MDA — Medapp SA Income Statement
0.000.00%
- PLN42.52m
- PLN47.12m
- PLN7.42m
- 44
- 21
- 10
- 12
Annual income statement for Medapp SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | PAS | PAS | PAS | PAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.02 | 12.7 | 6.73 | 5.09 | 7.42 |
Cost of Revenue | |||||
Gross Profit | 5.47 | 10.9 | 5.23 | 3.88 | 2.58 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.91 | 8.29 | 5.41 | 6.1 | 7.38 |
Operating Profit | 2.12 | 4.42 | 1.33 | -1.01 | 0.044 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.87 | 4.42 | 1.25 | -1.22 | -0.098 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.92 | 4.12 | 0.658 | -1.51 | -0.122 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.92 | 4.12 | 0.658 | -1.51 | -0.122 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.92 | 4.12 | 0.658 | -1.51 | -0.122 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.01 | 0.018 | 0.003 | -0.006 | -0 |
Dividends per Share |